Unibest

Pharmaceutical intermediates

Voxelotor Intermediates

4 pharmaceutical intermediates for Voxelotor. Indication: Anemia, Sickle Cel; Anemia, Hemolytic.

Submit a ProjectAll intermediates

About Voxelotor

Originator
Global Blood Therapeutics Inc
Indication
Anemia, Sickle Cel; Anemia, Hemolytic
Approved Date
11/25/2019
DS/DP
12/28/2032

Available intermediates

4 intermediates currently listed for Voxelotor. Request specifications, documentation or a quotation for any item below.

Voxelotor intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
(2-Chloro-3-pyridinyl)methanol42330-59-6//
1-Isopropyl-1H-pyrazole-5-boronic acid, pinacol ester1282518-60-8//
2-hydroxy-6-(methoxymethoxy)benzaldehyde84290-49-3//
3-(chloromethyl)-2-(1-isopropyl-1H-pyrazol-5-yl)pyridine hydrochloride1446321-95-4//

Other programs under V

Valbenazine Tosylate (NBI-98854)Varenicline TartrateVelpatasvirVenetoclaxVericiguatVibegronVilazodone HydrochlorideVONOPRAZAN FUMARATE

Building toward Voxelotor?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

Submit a Project Talk to the team

How can we help you?

Receive insights into the latest events and regulatory updates

Sent directly to your email

Get industry insights and Unibest news here

Contact Us →